Table 2:
Association of cancer directed treatment factors and physical and mental impairment at work, and change in employment among young adult cancer survivors working at any time from diagnosis to study participation.
| Chemotherapy † | Radiation ‡ | Surgery § | ||||||||||||||||||||
| n Chemotherapy/ n no Chemotherapy (%) | OR | 95% CI | n Radiation/ n no Radiation (%) | OR | 95% CI | n Surgery/ n no Surgery (%) | OR | 95% CI | ||||||||||||||
| Interfered with physical tasks required by job | ||||||||||||||||||||||
| No | 96 / 119 (44.7) | 1.00 | Ref | 80 / 135 (37.2) | 1.00 | Ref | 172 / 43 (80.0) | 1.00 | Ref | |||||||||||||
| Yes | 187 / 115 (61.9) | 1.97 | (1.22–3.11) | ** | 140 / 162 (46.4) | 1.66 | (1.08–2.41) | * | 240 / 62 (79.5) | 1.57 | (0.90–2.73) | |||||||||||
| Interfered with mental tasks required by job | ||||||||||||||||||||||
| No | 144 / 189 (43.2) | 1.00 | Ref | 122 / 211 (36.6) | 1.00 | Ref | 264 / 69 (79.3) | 1.00 | Ref | |||||||||||||
| Yes | 269 / 130 (67.4) | 3.22 | (2.15–4.79) | ** | 182 / 217 (45.6) | 1.39 | (0.99–1.94) | 321 / 78 (80.5) | 1.46 | (0.90–2.35) | ||||||||||||
| Extended paid time off from work, unpaid time off, or a change in your hours, duties or employment status | ||||||||||||||||||||||
| No | 64 / 108 (37.2) | 1.00 | Ref | 63 / 109 (36.6) | 1.00 | Ref | 137 / 35 (79.7) | 1.00 | Ref | |||||||||||||
| Yes | 352 / 212 (62.4) | 3.56 | (2.31–5.47) | ** | 243 / 321 (43.1) | 1.07 | (0.73–1.58) | 452 / 112 (80.1) | 1.21 | (0.71–2.08) | ||||||||||||
| Extended paid time off from work | ||||||||||||||||||||||
| No | 115 / 63 (64.6) | 1.00 | Ref | 77 / 101 (43.3) | 1.00 | Ref | 143 / 35 (80.3) | 1.00 | Ref | |||||||||||||
| Yes | 228 / 138 (62.3) | 1.02 | (0.62–1.67) | 165 / 201 (45.1) | 1.03 | (0.69–1.55) | 293 / 73 (80.1) | 0.54 | (0.54–1.00) | * | ||||||||||||
| Unpaid time off from work | ||||||||||||||||||||||
| No | 159 / 96 (62.4) | 1.00 | Ref | 119 / 136 (46.7) | 1.00 | Ref | 199 / 56 (78.0) | 1.00 | Ref | |||||||||||||
| Yes | 183 / 103 (64.0) | 1.39 | (0.79–2.36) | 122 / 164 (42.7) | 0.90 | (0.62–1.32) | 234 / 52 (81.8) | 1.37 | (0.79–2.36) | |||||||||||||
†
Adjusted for diagnosis (categorical), age (categorical), gender, education (categorical), insurance, radiation status, and surgery status.
‡
Adjusted for diagnosis (categorical), age (categorical), gender, education (categorical), insurance, chemotherpy status, and surgery status.
§
Adjusted for diagnosis (categorical), age (categorical), gender, education (categorical), insurance, chemotherapy status, and radiation status.
*
p-value <0.05
**
p-value <0.01